ArticleNPJ digital medicine2026
AI home monitoring for behavioral markers of cerebrovascular disease.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cerebrovascular disease (CeVD) is a major health concern in aging populations, and early identification is crucial for improving outcomes. Conventional diagnostic approaches are hospital-centered and limited in capturing disease risks from behavioral changes at home. We propose a framework to identify potential CeVD prodromal individuals and estimate diagnostic risk using behavioral and environmental data collected from contactless sensors in real-world homes. We used 13,362 samples (14-day windows) from 1224 older adults (598 healthy, 28 prodromal, 598 diagnosed) in South Korea. In-home behavioral and environmental factors, along with demographics and comorbidities, were used to develop models for three tasks. The framework achieved an area under the precision-recall curve of 0.85 for prodromal identification (Task 1), an area under the receiver operating characteristic curve of 0.91 for classifying diagnosed patients (Task 2), and a sensitivity of 95.12%, specificity of 96.97%, and accuracy of 96.53% for predicting imminent diagnostic risk within the prodromal group (Task 3). Model interpretation identified key digital behavioral markers, including frequent continuous activity and shorter inactive time during bedtime preparation hours (Task 1) and evening hours (Task 3). Our approach offers the potential to facilitate early detection of CeVD at home and requires further validation before clinical application.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.